Background-The circadian variation in the incidence of cardiovascular events may be attributable to the circadian changes in vascular contractility. The circadian rhythm of vascular contractility is determined by the interplay between the central and peripheral clocks. However, the molecular mechanism of the vascular intrinsic clock that generates the circadian rhythm of vascular contractility still remains largely unknown. Methods and Results-The agonist-induced phosphorylation of myosin light chain in cultured smooth muscle cells synchronized by dexamethasone pulse treatment exhibited an apparent circadian oscillation, with a 25.4-hour cycle length. The pharmacological inhibition and knockdown of Rho-associated kinase 2 (ROCK2) abolished the circadian rhythm of myosin light chain phosphorylation. The expression and activity of ROCK2 exhibited a circadian rhythm in phase with that of myosin light chain phosphorylation. A clock gene, RORα, activated the promoter of the ROCK2 gene, whereas its knockdown abolished the rhythmic expression of ROCK2. In the mouse aorta, ROCK2 expression exhibited the circadian oscillation, with a peak at Zeitgeber time 0/24 and a nadir at Zeitgeber time 12. The myofilament Ca 2+ sensitization induced by GTPγS and U46619, a thromboxane A2 analog, at Zeitgeber time 0/24 was greater than that seen at Zeitgeber time 12. The circadian rhythm of ROCK2 expression and myofilament Ca 2+ sensitivity was abolished in staggerer mutant mice, which lack a functional RORα. 
T he cardiovascular system displays circadian rhythms in some physiological parameters, including blood pressure. In addition, the occurrence of coronary artery events, such as myocardial infarction and angina pectoris, has a circadian variation with a peak during the morning.
1,2 These changes may be attributable to the diurnal variation of sympathetic nerve activity, plasma fibrinolytic activity, platelet aggregability, or vascular contractility. 3, 4 The circadian changes in the vascular tone and reactivity to adrenergic receptor agonists have been well documented. 5 However, the precise mechanism underlying the circadian rhythm of vascular contractility has not been fully elucidated.
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In mammals, the diurnal rhythm of biological processes is driven by the biological clock system. The molecular mechanism of the biological clock is based on the transcriptionaltranslational autoregulatory feedback loops composed of a set of clock genes. 6 The transcription factors CLOCK and BMAL1 work as a heterodimer to activate the transcription of the Cry and Per genes. 6 Once CRY and PER have reached a critical concentration, they repress the transactivation of CLOCK-BMAL1 and inhibit their own transcription. 6 Additional loops involving other clock genes, such as Rev-erb and Ror, interact with and modulate this central loop. 6 The circadian oscillation of the biological clock is then dictated by the rhythmic expression of genes, which generate the rhythm of physiological processes. The circadian rhythm of peripheral tissues is determined by the interplay between the central and peripheral clock mechanisms. The central clock influences the rhythm of the peripheral tissues by generating the circadian rhythm of neurohumoral cues. 6 Recently, the peripheral clock system has been shown to dominate in regulating the expression of several important genes in different organs under certain conditions. 7, 8 However, the role of the vascular intrinsic clock in the regulation of vascular contractility and its molecular mechanisms still remain elusive.
The present study thus aimed to clarify whether there is any intrinsic diurnal oscillation in the vascular contractility and, if so, to elucidate the underlying molecular mechanism. The importance of the endothelium in regulating the physiological vascular tone is well recognized; however, the smooth muscle also plays a fundamental role in determining the vascular contractility. 9, 10 Our investigations were initiated with cultured vascular smooth muscle cells to exclude any influence of the central clock or external cues. Because the phosphorylation of myosin light chain (MLC) plays a central role in the regulation of smooth muscle contraction, 11 the existence of circadian oscillation of MLC phosphorylation was first investigated. Accordingly, a clock gene RORα and its regulation of the expression of Rho-associated kinase 2 (ROCK2) were found to generate the circadian oscillation of MLC phosphorylation. The physiological significance of this clock mechanism in the regulation of vascular contractility was then evaluated using staggerer mutant mice, which lack a functional RORα. 12 As a result, the present study elucidated, for the first time, a pivotal role of ROCK2 in generating the intrinsic circadian rhythm of vascular contractility.
Methods
An expanded Methods sections is available in the online-only Data Supplement.
Cell Culture and Dexamethasone Pulse Treatment
The porcine coronary artery smooth muscle cells (PCSMCs) and porcine aortic smooth muscle cells were cultured in DMEM containing 10% FBS until semiconfluence for 3 to 4 days before experimental use. The cells at semiconfluence were incubated with 100 nmol/L of dexamethasone in growth medium for 2 hours to induce a synchronized circadian rhythm.
Animals
The original staggerer mutant mice, B6C3Fe-a/a-Rora sg mice (Jackson Laboratory, Bar Harbor, ME), were adjusted by crossing these mice with C57BL/6J inbred mice (CLEA Japan, Tokyo, Japan) for >10 generations. 13 The study protocol was approved by the animal care and use committee of Kyushu University. The animals were treated in accordance with the guidelines stipulated by the committee.
Real-Time Polymerase Chain Reaction Analysis
The total RNA was extracted from cultured cells and subjected to a real-time polymerase chain reaction analysis with FastStart SYBR Green Master kit using a LightCycler (Roche, Basel, Switzerland). The expression level of each mRNA was normalized to the level of β-actin obtained from the corresponding reverse transcription product.
Western Blot Analysis
The proteins from cultured smooth muscle cells or mice aortas were extracted in the lysis buffer and subjected to Western blot analysis. The immune complex was detected with an ECL plus detection kit (GE Healthcare, Buckinghamshire, United Kingdom). The light emission was detected and analyzed with a ChemiDoc XRS-J instrument and the computer program Quantity One (BioRad). The density of the immunoreactive band was normalized to that of the corresponding actin band to adjust for any possible variations in sample loading.
Phos-tag SDS-PAGE Analysis of the MLC Phosphorylation
MLC phosphorylation was evaluated with Phos-tag SDS-PAGE analysis, as described previously. 14 The level of MLC phosphorylation (PO 4 mol/MLC mol) was calculated as follows:
MLC phosphorylation = (P-MLC + PP-MLC × 2)/(MLC + P-MLC + PP-MLC)
where MLC, P-MLC, and PP-MLC indicate the optical density of the non-, mono-, and di-phosphorylated forms of MLC.
Transfection of Small Interfering RNA
Small interfering RNAs (siRNAs) were synthesized with a 3′-UU overhang by Dharmacon (Lafayette, CO). The siRNAs were transfected with the HVJ Envelope Vector Kit GenomONE (Ishihara Sangyo, Osaka, Japan).
Pull-Down Assay for the GTP-Bound Forms of RhoA
The GTP-bound form of RhoA in the cell extract was recovered using a RhoA-binding domain of ROCK2 as a (His) 6 -tagged pull-down probe and Ni
2+
-nitrilotriacetic acid resin. Equal amount of the resin eluates and cell lysates were subjected to an immunoblot analysis with an anti-RhoA antibody, as described above. January 1/8, 2013
by an antibody specific for P-MLC Ser19 ( Figure 1A ). The uppermost band was detected by an antibody specific for PP-MLC Thr18+Ser19 ( Figure 1A ). Thrombin and endothelin 1 were used as contractile stimuli in the present study, because they have been suggested to play a pathological role in cardiovascular diseases. 16, 17 Thrombin (1 U/mL) and endothelin 1 (100 nmol/L) transiently increased MLC phosphorylation with a peak at 2 minutes after the simulation ( Figure 1B) .
After the dexamethasone pulse treatment, the levels of MLC phosphorylation both at rest and 2 minutes after thrombin stimulation transiently increased with a peak at 4 to 8 hours and then returned within 20 to 24 hours to levels seen at 0 hours ( Figure 2A ). The level of MLC phosphorylation recorded 2 minutes after thrombin stimulation, but not the resting level, exhibited an oscillatory change, with peaks at 36 hours and 60 hours and a nadir at 48 hours ( Figure 2A ). The frequency analysis by an autoregressive model revealed that it had a 25.4-hour cycle length ( Figure 2B ). An analysis using the antibodies specific for PP-MLC Thr18+Ser19 and P-MLC Ser19 revealed a similar oscillatory change in the levels of PP-MLC Thr18+Ser19 but not P-MLC Ser19 ( Figure 2C ).
Role of ROCK2 in the Circadian Oscillation of the MLC Phosphorylation in Vascular Smooth Muscle Cells
MLC kinase (MLCK), protein kinase C (PKC), ROCK, and Zipper-interacting kinase (ZIPK) play a major role in the regulation of MLC phosphorylation. 10, 18 The inhibitors of MLCK (10 µmol/L of ML-9), PKC (1 µmol/L of GF109203), and ROCK (3 µmol/L of Y27632) were applied 10 minutes before and during thrombin stimulation. The treatment with these inhibitors had no effect on the cell viability (Table S1 , available in the online-only Data Supplement). All 3 of the inhibitors suppressed the thrombin-induced MLC phosphorylation to a similar level (≈0.5 PO 4 mol/MLC mol) at 24 hours after synchronization ( Figure 3A) . Only ROCK inhibitor abolished the circadian oscillation of MLC phosphorylation ( Figure 3A ). In line with these observations, the knockdown of ROCK2, but not MLCK or ZIPK, abolished the circadian oscillation of the MLC phosphorylation ( Figure 3B ). The level of expression of ROCK2, MLCK, and ZIPK after siRNA-mediated knockdown was 55.4 ± 6.3% (n=7), 50.9 ± 5.1% (n=6), and 64.9 ± 4.3% (n=9), respectively, of that seen with the control siRNA ( Figure 3B ).
ROCK phosphorylates MYPT1, a noncatalytic subunit of MLC phosphatase, at Thr696 and Thr853 in human MYPT1, whereas other kinases, including ZIPK, phosphorylate MYPT1 at Thr696. 18, 19 The phosphorylation of Thr853 thus reflects the circadian oscillation of ROCK activity. The phosphorylation of Thr853 induced by thrombin exhibited circadian oscillation with peaks at 36 and 60 hours and a nadir at 48 hours ( Figure 4A ). This circadian pattern was similar to that seen with the thrombin-induced MLC phosphorylation ( Figure 4A ). The phosphorylation of Thr696 exhibited no apparent circadian oscillation ( Figure 4A ).
The level of expression of ROCK2 mRNA and protein exhibited circadian changes ( Figure 4B ). The pattern of the change in the level of ROCK2 protein was similar to that seen with the phosphorylation of MLC and MYPT1 (Thr853). The level of rock2 mRNA oscillated with a phase that had a peak ≈4 hours earlier than the protein expression ( Figure 4B ). The expression of the ROCK2 protein also exhibited similar circadian changes in porcine aortic smooth muscle cell, with peaks at 32 to 36 hours and 60 hours ( Figure S2 , available in the online-only Data Supplement). In contrast, the level of the protein expression of MLCK, PKCα, and ZIPK exhibited no apparent circadian oscillation ( Figure 4C ). The level of the GTP-bound form of RhoA seen after thrombin stimulation also remained constant ( Figure 4D ).
Circadian Changes in the Phosphorylation of MLC and MYPT1 After Endothelin 1 Stimulation in Vascular Smooth Muscle Cells
The levels of PP-MLC Thr18+Ser19 and P-MYPT1 Thr853 seen 2 minutes after stimulation with 100 nmol/L of endothelin 1 exhibited a similar circadian change to those seen with thrombin stimulation, with peaks at 36 and 60 hours and a nadir at 48 hours ( Figure S3A and S3B, available in the online-only Data Supplement). The levels of P-MLC Ser19 and P-MYPT1 Thr696 exhibited no apparent circadian changes ( Figure S3A and S3B, available in the online-only Data Supplement). These 
Role of RORα in the Circadian Changes in the Transcription of ROCK2 in Vascular Smooth Muscle Cells
Among the regulatory elements for the known clock gene products, 2 ROR response elements (ROREs) separated by 102 to 108 nucleotides are preserved in the promoter region of the rock2 gene among various mammalian species (Table S2 , available in the online-only Data Supplement). REV-ERBα, REV-ERBβ, RORα, RORβ, and RORγ are all capable of binding to RORE. 20, 21 The luciferase promoter assay with the −1337 to +74 nucleotide region of the human rock2 gene showed that RORα and RORγ, but not RORβ, REV-ERBα or REV-ERBβ, increased the promoter activity >5-fold the level seen with control vectors in PCSMCs ( Figure 5A ). The endogenous expression of RORα exhibited circadian changes, with a phase that peaked ≈4 hours earlier than the ROCK2 protein expression ( Figure 5B versus Figure 4B ), whereas the expression of RORγ showed no apparent circadian oscillation ( Figure 5B ). The suppression of the RORα expression by siRNA abolished the circadian rhythm of the ROCK2 expression, whereas a control siRNA had no effect ( Figure 5C ).
RORα-Mediated Regulation of Circadian Changes in ROCK2 Expression and Myofilament Sensitivity to Ca 2+ in the Mouse Aorta
The expression of ROCK2 protein ( Figure 6A and 6B) but not ROCK1 protein ( Figure S4 , available in the online-only Data Supplement) in the aortas of wild-type mice kept under a 12-hour dark-light cycle exhibited a circadian oscillation, with a peak at Zeitgeber time (ZT) 0/24, which corresponds to ≈36 hours after dexamethasone pulse treatment in the cultured cells. 6, 15 The expression of RORα also exhibited a circadian change, with a phase peak 4 hours earlier than that of ROCK2 ( Figure 6A and 6B). In the aortas of staggerer mice, which lack a functional RORα, the ROCK2 expression did not show any apparent circadian changes ( Figure 6A and 6B). Instead, the level of ROCK2 protein in staggerer mice was similar to that seen at the nadir (ZT12) in the aortas of wild-type mice ( Figure 6C ). The level of MLCK was also similar between wild-type and staggerer mice at ZT12 ( Figure 6C ).
ROCK plays an important role in modulating the myofilament Ca 2+ sensitivity. 11, 18 The functional relevance of the RORα-mediated circadian expression of ROCK2 was evaluated using the α-toxin-permeabilized preparations, which allowed us to directly evaluate the myofilament Ca 2+ sensitivity by examining the contraction at a fixed concentration of Ca
2+
. GTPγS, a nonhydrolyzable GTP analog, was used to induce the myofilament Ca 2+ sensitization.
14 First, the Ca 2+ -dependent contraction was examined by increasing the Ca 2+ concentrations in a stepwise manner in the absence of any simulation of Ca 2+ sensitivity. The pCa 2+ -tension relationship of this contraction did not differ between ZT0 and ZT12 in both wild-type and staggerer mice ( 
Circadian Changes in Myofilament Sensitivity to Ca

2+ and MLC Phosphorylation Induced by U46619 in the Mouse Aorta
The present study examined whether the circadian change in myofilament Ca 2+ sensitivity was observed for the receptormediated contraction. The Ca 2+ -sensitizing effect of a thromboxane A2 analog, U46619, was examined at ZT0 and ZT12 in the α-toxin permeabilized aortic ring preparations. The contraction was induced by 1 µmol/L of U46619 in the presence of 10 µmol/L of GTP during the 0.5-µmol/L Figure 8A ). 22 The extent of the contraction seen at ZT0 was significantly greater than that seen at ZT12 in wild-type mice ( Figure 8A ). In contrast, there was no significant difference in the U46619-induced contraction between ZT0 and ZT12 in the staggerer mice ( Figure 8A ).
In accordance with the diurnal change in the Ca 2+ -sensitizing effect of U46619, the U46619-induced MLC phosphorylation also exhibited a circadian change ( Figure 8B ). MLC phosphorylation was analyzed 5 and 25 minutes after the simulation with 1 µmol/L of U46619 in the presence of 10 µmol/L of GTP during the 0.5-µmol/L Ca 2+ -induced contractions. The MLC phosphorylation at ZT0 at both 5 and 25 minutes was significantly greater than that seen at ZT12 in the wild-type mice ( Figure 8B ). In contrast, there was no significant difference in the U46619-induced MLC phosphorylation between ZT0 and ZT12 in the staggerer mice ( Figure 8B ).
Discussion
The present study elucidated, for the first time, the existence of the vascular clock mechanism intrinsic to the smooth muscle that generates the circadian oscillation of the myofilament Ca 2+ sensitivity with a peak at the beginning of the light phase, in a manner independent of external cues. The present study further delineated the signaling pathway from the clock gene to the circadian rhythm of the myofilament Ca 2+ sensitivity. The circadian oscillation of the expression of a clock gene, RORα, appears to be translated to the oscillation of ROCK2 transcription, which in turn generates the oscillation of MLC phosphorylation in response to contractile stimuli. ROCK2-mediated potentiation of MLC phosphorylation is an important mechanism underlying myofilament Ca 2+ sensitivity. 23, 24 Myofilament Ca 2+ sensitivity plays a critical role in determining the extent of the vascular response to contractile stimuli and vascular contractility. 18, 24 As a result, the present study suggests ROCK2 to be a key oscillator generating the circadian rhythm of myofilament Ca 2+ sensitivity and vascular contractility. The circadian oscillation of the MLC phosphorylation induced by thrombin and endothelin 1 was consistently observed by the 2 different analyses. The Phos-tag SDS-PAGE analysis allowed us to perform a stoichiometric evaluation of MLC phosphorylation for each time point in a self-contained manner, thus minimizing the influence of the variations in the amount of proteins loaded. The analysis with phosphor-specific antibodies further revealed that the circadian oscillation of the agonist-induced MLC phosphorylation was mainly attributed to PP-MLC Thr18+Ser19 . In the Phos-tag SDS-PAGE analysis, both the resting and stimulated levels of MLC phosphorylation transiently increased during the 4 to 8 hours after the dexamethasone pulse treatment. Pulse treatment with dexamethasone has been shown to induce an early surge of the expression of various genes, including not only clock genes, such as per1, but also c-fos or β-actin, which do not show any oscillation. 25, 26 Therefore, the transient increase in MLC phosphorylation may be attributable to the expression of not only clock-controlled genes but also unrelated genes that can affect the MLC phosphorylation. As a result, most of the analyses of circadian rhythm were performed starting from 24 hours after the dexamethasone pulse treatment.
Because the circadian oscillation of MLC phosphorylation was observed with both thrombin and endothelin 1, the mechanisms regulating MLC phosphorylation common to both agonists are likely responsible for the oscillation. MLCK is a major kinase that phosphorylates MLC in a Ca 2+ -dependent manner, 27 whereas ROCK, ZIPK, and integrin-linked kinase phosphorylate MLC in a Ca 2+ -independent manner. 18 Any of these kinases could induce PP-MLC Thr18+Ser19 . 18, 28 On the other hand, the dephosphorylation of MLC is mainly catalyzed by a type 1 phosphatase consisting of 3 subunits. 29 The activity of this MLC phosphatase is suppressed either when MYPT1 is phosphorylated by ROCK, ZIPK, or integrin-linked kinase or when an inhibitor protein, CPI-17, is phosphorylated by ROCK or PKC. 18, 29 The pharmacological inhibitors of MLCK, PKC, and ROCK suppressed the thrombin-induced MLC phosphorylation to a similar level. However, only the ROCK inhibitor abolished the circadian oscillation of the MLC phosphorylation. The knockdown of MLCK, ZIPK, and ROCK2 suppressed the thrombin-induced MLC phosphorylation to a similar level at a nadir, whereas only ROCK2 knockdown abolished the circadian oscillation. It should be noted that an ≈50% reduction of ROCK2 expression was sufficient to abolish the circadian rhythm of MLC phosphorylation. The specificity of this phenomenon was supported in that only ROCK2 knockdown was effective in suppressing the circadian rhythm of MLC phosphorylation, whereas the degree of knockdown was similar among the 3 kinases.
There are 2 isoforms of ROCK, ROCK1 and ROCK2, which share 65% overall homology at the amino acid level.
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ROCK2 is the major isoform in gizzard smooth muscle, and ROCK2 plays a predominant role in the regulation of vascular smooth muscle contraction. 28, 31 An in silico analysis revealed that the promoter regions of the mammalian rock1 genes lack any regulatory element for the known clock genes. Indeed, no obvious circadian rhythm was observed for the ROCK1 protein expression in the aorta of wild-type mice ( Figure S4 , available in the online-only Data Supplement). Therefore, ROCK2 is suggested to play a key role in the circadian rhythm of MLC phosphorylation. The present study further demonstrates that the circadian oscillation of the expression and activity of ROCK2 correlate with the circadian rhythm of the MLC phosphorylation. ROCK is known to phosphorylate MYPT1 at both Thr696 and Thr853 in humans, with a 3-fold preference for Thr853 over Thr696.
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Thr696 is also phosphorylated by other kinases, including ZIPK and integrin-linked kinase. 18, 19 Therefore, the phosphorylation of Thr853 more accurately indicates the activity of ROCK. The observations of the present study thus indicated that the rhythm of ROCK2 expression was correlated with the rhythm of activity (the phosphorylation of Thr853). The circadian oscillation of Thr853 phosphorylation and the in-phase oscillation of MLC phosphorylation were similarly observed after stimulation with thrombin and endothelin 1. A key role of ROCK2 in generating the circadian rhythm of the MLC phosphorylation is thus consistent as a mechanism common to both agonists. ROCK can modulate MLC phosphorylation either by inhibiting MLC phosphatase activity via the phosphorylation of MYPT1 or CPI-17 or by directly phosphorylating MLC. 18, 29 However, the basal level of MLC phosphorylation did not shown any apparent circadian oscillation. The circadian oscillation of MLC phosphorylation was apparently attributed to the agonist stimulation. Furthermore, the substrate specificity of ROCK for MYPT1 (Michaelis constant value, 0.1-0.2 µmol/L) was higher than that for MLC (2.5-5.0 µmol/L). 31 It is therefore conceivable that ROCK2 generates the circadian oscillation of MLC phosphorylation mainly through the inhibition of the MLC phosphatase activity.
We concluded that the oscillation of ROCK2 expression was regulated by a clock gene, RORα, based on the following observations: the luciferase promoter assay demonstrated that the human rock2 promoter was responsive to RORα and RORγ. The expression of RORα, but not RORγ, exhibited circadian oscillation in phase with that of ROCK2 mRNA. The rhythmic expression of ROCK2 was abolished by knocking down the expression of RORα. The 2 ROREs, which are separated by a 102-to 108-nucleotide interval, are well preserved in the promoter regions of the mammalian rock2 genes (Table  S2 , available in the online-only Data Supplement). RORE is known to be responsible for gene expression during the dark phase. 20 This role of RORE is consistent with the observation that the expression of ROCK2 protein peaked at 36 and 60 hours after the dexamethasone pulse treatment, both of which correspond with the transition from the dark phase to the light phase. 6, 15 There are 3 isoforms of ROR, and the rhythmic expression of each isoform shows tissue specificity. 12, 21 RORα expression is rhythmic in white adipose tissue but not in brown adipose tissue, liver, or muscle, whereas RORγ expression is rhythmic specifically in brown adipose tissue and liver. 21 RORα thus appears to play a major role in the transcriptional regulation of the circadian rhythm of ROCK2 expression in vascular smooth muscle.
The physiological significance of the observations in the cultured smooth muscle cells was demonstrated by using the aortas of staggerer mice, which lack a functional RORα. 12 The use of the aorta is supported by the observation that the circadian oscillation of ROCK2 expression was similarly observed in both PCSMCs and porcine aortic smooth muscle cells. As a result, the RORα-mediated circadian expression of ROCK2 was demonstrated to occur both in vivo and in culture. The functional significance of the oscillation of ROCK2 expression in the regulation of smooth muscle contraction was demonstrated by using α-toxin-permeabilized preparations. The contraction of smooth muscle is regulated by Ca 2+ signaling and the change in the myofilament Ca 2+ sensitivity.
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ROCK plays an important role in modulating the myofilament Ca 2+ sensitivity. 11, 18 The use of permeabilized preparations allowed the focused investigation on the myofilament Ca 2+ sensitivity and thereby enabled the successful detection of the diurnal changes in the myofilament Ca 2+ sensitivity as a consequence of the circadian oscillation of ROCK2 expression. The results indicated that the myofilament Ca 2+ sensitivity increased in association with an increase in MLC phosphorylation when the ROCK2 expression reached a peak (ZT0/24) and decreased when the ROCK2 expression reached a nadir (ZT12). These diurnal changes were abolished in the staggerer mice. In contrast, there were no significant diurnal changes in the Ca 2+ -dependent contractile mechanism. These findings thus suggest that the RORα-mediated circadian oscillation of ROCK2 expression is translated specifically to the oscillation of the myofilament Ca 2+ sensitivity by modulating the MLC phosphorylation.
It was noticed that the Ca 2+ -tension relationship of the Ca 2+ -induced contraction in the staggerer mice shifted to the left of that obtained in the wild-type mice. The precontractions induced by Ca 2+ before the application of GTPγS or U46619 in the staggerer mice were higher than those seen in the wildtype mice. These observations suggest that the activity of some Ca 2+ -dependent contractile mechanisms was enhanced in staggerer mice. However, the level of MLCK expression -induced contraction in staggerer mice remains to be investigated.
In conclusion, the present study revealed that the vascular intrinsic clock mechanism involving RORα generates the circadian rhythm of myofilament Ca 2+ sensitivity. ROCK2 was identified as a key oscillator generating the circadian rhythm of the response of MLC phosphorylation and myofilament Ca 2+ sensitivity. It is conceivable that the interplay between the central and the peripheral clocks plays an important role in determining the circadian rhythm of vascular contractility. How this vascular intrinsic rhythm of myofilament Ca 2+ sensitivity interplays with the external cues from the central clock mechanism remains to be elucidated. Furthermore, the intrinsic rhythm of the myofilament Ca 2+ sensitivity peaks at the beginning of the light phase, when the occurrence of cardiovascular diseases also peaks. The increased ROCK activity is suggested to play an important role in the pathogenesis of coronary vasospasm in both animal models and patients with vasospastic angina. 10, 32, 33 The ROCK-mediated oscillation of myofilament Ca 2+ sensitivity is therefore suggested to underlie the onset of cardiovascular events. However, such a pathological role of the vascular clock mechanism remains to be investigated. 
SUPPLEMENTAL MATERIAL Expanded Methods
Cell culture and dexamethasone pulse treatment
The cultured porcine coronary artery and aortic smooth muscle cells were prepared as described previously. 1 The cells were grown in Dulbecco's Modified Eagle Medium (Sigma, St. Louis, MO, U.S.A.) supplemented with 10% fetal bovine serum, penicillin and streptomycin in a 37 o C incubator maintained at 5% CO 2 . The cells were cultured until semi-confluence for 3-4 days. The cells at semi-confluence were incubated with 100 nmol/L dexamethasone in growth media for 2 hr to induce a synchronized circadian rhythm.
Animals
Staggerer mice carry an intragenic deletion in the coding region of the rorα gene, which causes a frame shift in the coding region, and leads to the expression of the dominant negative RORα, thereby leading to a functional knockout phenotype. 2 The original genetic background of the B6C3Fe-a/a-Rora sg mice obtained from Jackson Laboratory (Bar Harbor, ME, U.S.A) was adjusted by crossing these mice with C57BL/6J inbred mice purchased from CLEA Japan (Tokyo, Japan) for more than 10 generations, as described previously. 3 Homozygous staggerer mice were obtained by crossing heterozygous male and female breeders. The identification of homozygotes was carried out by PCR genotyping as described by Jackson Laboratory. The C57BL/6J (CLEA Japan) mice were used as wild-type controls.
The male wild-type and homozygous staggerer mice (6-7 weeks old) were housed in a temperature-controlled room under a 12 hour light/12-hour dark cycle with ad libitum access to food and water. Zeitgeber times (ZT) 0 and 12 were designated as lights on and off, respectively. The study protocol was approved by the Animal Care and Use Committee of Kyushu University. The animals were treated in accordance with the guidelines stipulated by the committee.
Real-time PCR analysis
The total RNA was extracted from cultured cells using the RNeasy kit (Qiagen, Hilden, Germany) and cDNA was synthesized using 2 µg total RNA, a random primer, and ReverTra-plus reverse transcriptase (Toyobo, Osaka, Japan). In Phos-tag SDS-PAGE analysis, they were immunologically detected using a primary antibody for β-actin (Sigma) and an appropriate secondary antibody conjugated with horseradish peroxidase, because the amount of β-actin in the protein samples used for the Phos-tag SDS-PAGE analysis was too small to be quantitatively detected by naphthol blue black staining. The density of the immunoreactive band was normalized to the density of the corresponding actin band to adjust for any possible variations in sample loading. The image capture time was adjusted to keep the intensity of the imaging below the maximum limit of the system, and therefore within a linear range.
Phos-tag SDS-PAGE analysis of the MLC phosphorylatyion
The extracts of cultured smooth muscle cells were prepared as described above. The samples for the analysis of the α-toxin-permeabilized aortic ring preparations were obtained during the measurement of tension, as previously described. 4 The bathing buffer was promptly The siRNAs were transfected with the HVJ Envelope Vector Kit GenomONE (Ishihara Sangyo, Osaka, Japan) on the next day after plating the cells after being incorporated into the HVJ-envelope vector according to the manufacturer's instructions. The cells were exposed to 100 nmol/L siRNA incorporated in the vector for 2 hr. Thereafter, the cells were cultured for 3 days before subjecting them to dexamethasone pulse treatment.
Pull-down assay for the GTP-bound forms of RhoA
The cell extract was prepared in buffer consisting of 50 mmol/L Tris-HCl, pH 7.2, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 500 mmol/L NaCl, 10 mmol/L MgCl 2 , 10 µg/mL leupeptin, 10 µg/mL aprotinin, and 10 µmol/L 4-aminidophenylmethane sulfonyl fluoride. The 500 µg protein samples were incubated with 30 µg of a pull-down probe for 45 min at 4°C. The RhoA-binding domain (RB; residues 941-1075) of ROCK2 tagged with a (His) 6 tag was used as a pull-down probe, as previously described. 5 The mixture was then incubated with Ni 2+ -nitrilotriacetic acid resin (Qiagen) at 4°C for 1 h. The resin was collected by a brief centrifugation and thoroughly washed in the resin wash buffer (50 mmol/L Tris-HCl, 1% Triton X-100, 150 mmol/L NaCl, 10 mmol/L MgCl 2 , 10 µg/mL leupeptin, 10 µg/mL aprotinin, 10 µmol/L 4-aminidophenylmethane sulfonyl fluoride, pH 7.2), and the bound protein was then eluted in SDS-sample buffer (50 mmol/L Tris-HCl, pH 6.8, 2% SDS, 5% glycerol, 5% β-mercaptoethanol, 0.01% NaN 3 , 0.01% bromophenol blue) by heating at 100°C for 5 min. Equal volumes (20 μl) of the resin eluates and 5 µg cell lystes were subjected to SDS-PAGE and an immunoblot analysis with an anti-RhoA antibody (sc-418; Santa Cruz). The chemiluminescence detection of RhoA was as described above. The bands of the pull-down probe and actin were detected with naphthol blue black staining after immunoblot detection. The densities of RhoA in the resin eluates and the cell lysates were normalized to those of the pull-down probe and actin, respectively, and then were used to obtain the GTP-bound RhoA/total RhoA ratios.
Construction of the luciferase reporter plasmid for the human rock2 promoter assay
The promoter region of the human rock2 gene was obtained by screening a λ Dash II human genomic library (Agilent Technology, Tokyo, Japan) with a probe obtained by PCR amplification of a 1734-bp fragment of the human rock2 gene from human leukocyte genomic DNA. The PCR primers were designed based on the sequences in the NCBI database (Genomic contig NT_005334.15). A promoter region of the rock2 gene in the genomic clone was then amplified by PCR and subcloned into a luciferase reporter plasmid pGL3-basic (Promega, Tokyo, Japan). The sequences of the insert were confirmed to be identical to those of the clone of the genomic library. The reporter plasmid was thus pGL3-rock2 (−1337 to +74). The number in parentheses indicates the residue numbers at the 5′-and 3′ ends of the promoter region, respectively, while the first base of the first exon was assigned to be +1.
Luciferase assay
The cells were transfected 24 hr after the initial plating, with 2 µg pGL3-rock2 (−1337 to +74), 1 µg expression vector of clock gene (Origene, Rockville, MD, U.S.A.) and 0.5 µg phRL-TK (Promega) in 2 ml DMEM containing 10 µl lipofectamine (Invitrogen). The culture medium was replaced 6 hr after transfection, and the promoter activity was evaluated 32 hr after transfection. The clock genes examined were pCMV-XL4-REV-ERBα, pCMV-XL4-RORα, pCMV-XL5-REV-ERBβ, pCMV-XL5-RORβ, and pCMV-XL5-RORγ.
The cells were washed in PBS twice, and then were lysed in passive lysis buffer (Promega).
The lysates were kept frozen at −80 o C until use. After thawing and clarification of the lysates by a brief centrifugation on a tabletop microcentrifuge (13,000×g, 30 sec, room temperature), the luciferase activity was determined using the dual-luciferase reporter assay system (Promega) and a Lumat LB9507 luminometer (Berthold Technologies, Bad Wildbad, Germany). The activity of firefly luciferase was normalized to that of renilla luciferase, and the value obtained with the empty vector, pCMV-XL4 or pCMV-XL5, was considered to be 1.
Tension measurement in the α-toxin-permeabilized preparations of mouse aortas
At the indicated Zeitgeber times, mice were euthanized under pentobarbital anesthesia. The ascending aorta was then immediately excided and cut into ring preparations. Next, the aortic rings were permeabilized with 5,000 units/mL staphylococcal α-toxin (Sigma, St. Louis, MO, USA) in cytosolic substitution solution (CSS) for 60 min at 30 o C, as previously described. 4, 6 These permeabilized preparations were then mounted between two tungsten wires and were stretched to 1.5-fold their resting length. After obtaining complete relaxation in Ca 2+ -free CSS, the experimental protocol was started, and the tension development was recorded at 
Other materials
Thrombin and endothelin-1 were purchased from Sigma and the Peptide Institute (Osaka, Japan), respectively. ML-9, GF109203 and Y27632 were purchased from Calbiochem (La Jolla, CA, USA).
Data analysis
The data are expressed as the means ± SEM of the indicated number of experiments or mice.
Either Steel's test or Student's t-test was used to determine the statistical significance of the differences among groups or between two groups, respectively, as indicated in the figure legends. A value of P < 0.05 was considered to be statistically significant. 
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